Wells Fargo
IPSC icon

Wells Fargo’s Century Therapeutics IPSC Stock Holding History

Wells Fargo’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
148,915
+148,875
+372,188% +$340K ﹤0.01% 4827
2026
Q1 		$90 Hold
40
– – ﹤0.01% 6514
2025
Q4 		$40 Buy
+40
New +$24 ﹤0.01% 6570
2025
Q3 		– Sell
-861
Closed -$481 – 7239
2025
Q2 		$481 Sell
861
-27,977
-97% -$15K ﹤0.01% 6376
2025
Q1 		$13.7K Buy
28,838
+622
+2% +$467 ﹤0.01% 5815
2024
Q4 		$28.5K Buy
28,216
+5,981
+27% +$8.14K ﹤0.01% 5668
2024
Q3 		$38K Buy
22,235
+2,077
+10% +$4.07K ﹤0.01% 5445
2024
Q2 		$51.4K Buy
20,158
+11,895
+144% +$37.6K ﹤0.01% 5282
2024
Q1 		$34.5K Buy
8,263
+1,060
+15% +$4.49K ﹤0.01% 5395
2023
Q4 		$23.9K Buy
7,203
+1,422
+25% +$2.59K ﹤0.01% 5573
2023
Q3 		$11.6K Sell
5,781
-3,124
-35% -$8.31K ﹤0.01% 5765
2023
Q2 		$28.1K Buy
8,905
+5,321
+148% +$17.2K ﹤0.01% 5633
2023
Q1 		$12.4K Buy
+3,584
New +$15.7K ﹤0.01% 5788
2022
Q4 		– Sell
-57
Closed -$1K – 7586
2022
Q3 		$1K Sell
57
-138
-71% -$1.45K ﹤0.01% 6368
2022
Q2 		$2K Sell
195
-13,713
-99% -$135K ﹤0.01% 6332
2022
Q1 		$175K Sell
13,908
-943
-6% -$12.5K ﹤0.01% 5053
2021
Q4 		$235K Buy
14,851
+14,793
+25,505% +$278K ﹤0.01% 5180
2021
Q3 		$1K Buy
+58
New +$1.57K ﹤0.01% 6723

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Wells Fargo's IPSC Position: Q2 2026 in Review

Wells Fargo increased its Century Therapeutics (IPSC) stake by 372,188% in Q2 2026, buying an estimated $340K and bringing the position to 148,915 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #4827.

Wells Fargo first reported a position in IPSC in Q3 2021 and has held it in 18 quarters since. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Wells Fargo held 148,915 shares of Century Therapeutics worth $365K as of Q2 2026.
  • Wells Fargo bought 148,875 Century Therapeutics shares in Q2 2026, an estimated $340K.
  • Century Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4827 holding.
  • Wells Fargo first reported a position in Century Therapeutics in Q3 2021 and has held it in 18 quarters since.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.